» Authors » Tomasz Wielkoszynski

Tomasz Wielkoszynski

Explore the profile of Tomasz Wielkoszynski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 306
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Wielkoszynski T, Zalejska-Fiolka J, Strzelczyk J, Owczarek A, Cholewka A, Krawczyk A, et al.
Oxid Med Cell Longev . 2019 Dec; 2019:1983975. PMID: 31827670
Objective: Cholesterol oxidation products have an established proatherogenic and cytotoxic effect. An increased exposure to these substances may be associated with the development of atherosclerosis and cancers. Relatively little, though,...
12.
Stanek A, Romuk E, Wielkoszynski T, Bartus S, Cieslar G, Cholewka A
Oxid Med Cell Longev . 2019 Sep; 2019:7524878. PMID: 31485298
Objective: The aim of the study was to estimate the impact of whole-body cryotherapy (WBC) and subsequent kinesiotherapy on oxidative stress and lipid profile when performed in a closed cryochamber...
13.
Szumska M, Damasiewicz-Bodzek A, Czubilinska J, Dlugaszek M, Gawlik K, Krywult A, et al.
Cardiovasc Toxicol . 2018 Oct; 19(2):120-128. PMID: 30302668
Pregnancy-associated plasma protein A (PAPP-A) is a high-molecular zinc-binding metalloproteinase that was first detected in the serum of pregnant women. It can also be detected in men and non-pregnant women....
14.
Wielkoszynski T, Moghaddam A, Backman A, Broden J, Piotrowski R, Mond-Paszek R, et al.
Eur J Clin Microbiol Infect Dis . 2018 Sep; 37(12):2301-2306. PMID: 30238343
Yersiniosis is a foodborne infection caused by Yersinia enterocolitica or Yersinia pseudotuberculosis. Although yersiniosis is most often self-limiting, some patients develop chronic infections, such as reactive arthritis, glomerulonephritis, or myocarditis,...
15.
Stanek A, Cholewka A, Wielkoszynski T, Romuk E, Sieron A
Oxid Med Cell Longev . 2018 Jun; 2018:7365490. PMID: 29854091
Objective: The aim of the study was to estimate the impact of whole body cryotherapy (WBC) on oxidative stress when performed in a closed cryochamber on patients with ankylosing spondylitis...
16.
Wielkoszynski T, Zalejska-Fiolka J, Strzelczyk J, Owczarek A, Cholewka A, Furmanski M, et al.
Mediators Inflamm . 2018 May; 2018:2784701. PMID: 29713239
Objective: Oxidized cholesterol derivatives are thought to exert atherogenic effect thus adversely affecting vascular endothelium. The aim of the study was to assess the effect of 5,6-epoxycholesterol on experimentally induced...
17.
Stanek A, Cholewka A, Wielkoszynski T, Romuk E, Sieron A
Mediators Inflamm . 2018 Feb; 2018:8592532. PMID: 29483842
Objective: The aim of the study was to estimate the impact of whole-body cryotherapy (WBC) on cardiovascular risk factors in patients with ankylosing spondylitis (AS). Material And Methods: We investigated...
18.
Stanek A, Cholewka A, Wielkoszynski T, Romuk E, Sieron K, Sieron A
Oxid Med Cell Longev . 2017 Sep; 2017:9712536. PMID: 28883908
Objective: The primary aim of the study was to assess levels of oxidative stress markers, soluble CD40 ligand (sCD40L), serum pregnancy-associated plasma protein-A (PAPP-A), and placental growth factor (PlGF) as...
19.
Stanek A, Sieron-Stoltny K, Romuk E, Cholewka A, Wielkoszynski T, Cieslar G, et al.
Adv Clin Exp Med . 2016 Dec; 25(6):1281-1291. PMID: 28028984
Background: Whole-body cryostimulation (WBC) is the therapeutic exposure of the total human body (without underwear) to a very low temperature (below -100°C) for 120-180 s. Currently, WBC is used more...
20.
Zalejska-Fiolka J, Wielkoszynski T, Rokicki Jr W, Dabrowska N, Strzelczyk J, Kasperczyk A, et al.
Biomed Res Int . 2015 Dec; 2015:827879. PMID: 26634212
We hypothesized that addition of substances with antioxidant activity could decrease the concentrations of biomarkers of oxidative stress and inflammatory process, thus inhibiting nonalcoholic steatohepatitis development. We investigated the influence...